Approval · Notice of Compliance 28791 · 2022
PERSANTINE: Notice of Compliance 28791
Issued August 18, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28791
- Date
- August 18, 2022
- Company
- Glenwood Gmbh Pharmazeutische ErzeugnisseMunich, --, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the inner and outer labels Conversion of Product Monograph to 2020 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PERSANTINE | Not yet assigned | — |
Medicinal ingredients
- DIPYRIDAMOLE 5 MG per ML